Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for MYR Group March 1 2024

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Finance_Business (1)
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

MYR Group (NASDAQ: MYRG) Analyst Ratings Update – March 1, 2024

In recent months, analysts have shared a mix of opinions on MYR Group, showcasing a range of bullish and bearish sentiments. Here is a breakdown of the latest analyst ratings and price targets:

Total Ratings:
– Bullish: 3
– Neutral: 1

Recent Trends:
– Bullish in the Last 30 Days: 1
– Neutral 1 Month Ago: 1

Price Targets:
– Average Target: $170.5
– High Estimate: $185.00
– Low Estimate: $164.00
– Average Target Increase: 7.23% from the previous average of $159.00

Recent Analyst Actions:
– Stanley Elliott (Stifel): Raised Buy rating to $185.00
– Brian Russo (Sidoti & Co.): Maintained Neutral rating at $165.00
– Ati Modak (Goldman Sachs): Announced Buy rating with a $164.00 price target

Analysts’ assessments and adjustments offer valuable insights into MYR Group’s current standing, reflecting responses to market conditions and company performance.

For a more detailed overview, please refer to the original sources.

MYR Group Inc. (MYRG) Stock Soars on Strong Performance and Positive Outlook – March 1, 2024

On March 1, 2024, MYR Group Inc. (MYRG) had a strong performance in the stock market. The company’s stock was trading near the top of its 52-week range and above its 200-day simple moving average, indicating positive price momentum. The price of MYRG shares increased by $1.39 since the previous market close, representing a 0.86% rise. The stock opened at $164.48, which was $2.02 higher than its previous close. MYR Group Inc. is a leading specialty contractor serving the electrical infrastructure market in the United States and Canada. Investors may have been drawn to MYRG stock on March 1st due to the company’s strong financial performance and positive outlook. Overall, MYRG had a solid performance on March 1, 2024, with the stock showing positive price momentum and strong investor interest.

MYRG Stock Shows Promising Performance with Strong Financial Results in 2023

On March 1, 2024, MYRG stock showed promising performances as the company reported strong financial results for the past year. According to data from CNN Money, MYRG’s total revenue for the year stood at $3.64 billion, marking a 21.12% increase from the previous year. In the fourth quarter alone, the company generated $1.00 billion in total revenue, holding flat compared to the previous quarter.

Net income for MYRG also saw positive growth, with the company reporting $90.99 million for the year, representing a 9.13% increase from the previous year. In the fourth quarter, net income stood at $24.04 million, showing an 11.76% increase from the previous quarter.

Earnings per share (EPS) for MYRG showed a steady increase, with the company reporting $5.40 for the year, a 10.05% increase from the previous year. In the fourth quarter, EPS was reported at $1.43, holding flat compared to the previous quarter.

Overall, MYRG’s strong financial performance for the past year reflects the company’s ability to drive revenue growth and increase profitability. Investors may view these results positively, as they indicate that the company is on a solid path towards sustainable growth and profitability.

Tags: MYRG
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
DrugRetailers Trading online

Stitch Fix Prepares to Unveil Quarterly Earnings Amidst Investor Caution

Technology Blockchain Markets and money

Stifel Analyst Reiterates Buy Rating on Unity Software with Increased Price Target

Finance_Investment (2)

Acme United Reports Q4 2023 Earnings Sales Fall Short of Estimates

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com